Kalaris Therapeutics, Inc. (KLRS)
NASDAQ: KLRS · Real-Time Price · USD
4.450
-0.175 (-3.78%)
At close: Oct 10, 2025, 4:00 PM EDT
4.340
-0.110 (-2.47%)
After-hours: Oct 10, 2025, 6:37 PM EDT

Kalaris Therapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 20202019
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019
Selling, General & Admin
49.4842.9248.2652.3349.0821.65
Upgrade
Research & Development
21.6412.34133.07118.87120.7449.66
Upgrade
Other Operating Expenses
-10.1918.57---
Upgrade
Total Operating Expenses
71.1265.44199.9171.2169.8271.31
Upgrade
Operating Income
-71.12-65.44-199.9-171.2-169.82-71.31
Upgrade
Interest Income
-5.495.731.881.321.33
Upgrade
Other Non-Operating Income (Expense)
-1.193.620.35-2.450.2
Upgrade
Total Non-Operating Income (Expense)
-6.679.362.23-1.141.53
Upgrade
Pretax Income
-71.12-58.77-190.54-168.98-170.96-69.78
Upgrade
Provision for Income Taxes
--0.130.27-1.01-
Upgrade
Net Income
-71.12-58.77-190.42-168.71-171.96-69.78
Upgrade
Net Income to Common
-71.12-58.77-190.42-168.71-171.96-69.78
Upgrade
Shares Outstanding (Basic)
4655776327
Upgrade
Shares Outstanding (Diluted)
4655776327
Upgrade
Shares Change (YoY)
18.55%10.70%-94.10%22.10%133.41%1991.66%
Upgrade
EPS (Basic)
-8.00-11.73-42.09-2.20-2.74-2.59
Upgrade
EPS (Diluted)
-8.00-11.73-42.09-2.20-2.74-2.59
Upgrade
Free Cash Flow
-79.19-67.71-124.45-142.05-106.35-61.05
Upgrade
Free Cash Flow Per Share
-1.72-13.52-27.51-1.85-1.69-2.27
Upgrade
EBITDA
-71.12-65.3-191.61-168.64-168.7-71.24
Upgrade
EBIT
-71.12-65.44-199.9-171.2-169.82-71.31
Upgrade
Effective Tax Rate
0.00%0.00%-0.07%-0.16%0.59%0.00%
Upgrade
Updated Jun 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q